FDA Takes Aim at Drug Ads: What It Means for Compounding Pharmacies, Medspas and Telehealth Companies
Stuart Pape and Suzanne Bassett discuss the FDA’s heightened enforcement of direct-to-consumer advertising rules and what it could mean for compounding pharmacies, medspas and telehealth companies.
